Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The drug targets a protein that suppresses tooth growth, aiming ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re one of the millions of people who have a gaping space in your gums where a tooth used to be, there’s reason to hope you ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in genetics, molecular biology, and regenerative medicine, that dream is ...

This could be a game changer. The post Plans Accelerated for Human Trials of Tooth Regeneration appeared first on Futurism.

Tooth regrowth drug TRG035 is moving towards Phase II trials in patients with severe congenital hypodontia after new funding.

First highlighted as part of a study in 2021, a tooth-regrowing drug is set to finally enter human testing this year. We covered plans for the drug to come to clinical trials last year, and now, it ...

It may very well be possible to grow new teeth sometime in the future. In fact, a Japanese company working on a tooth-growing drug is just now slated to enter clinical trials, making it the world's ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

The ongoing Phase I trial focuses purely on human safety. The study began in late 2024 and wrapped up its initial 11 month tracking window. While final results are pending, researchers note that ...